Brain Tumor Reports
48

Volume 19 Number 12
December 2017


Home > Publications > Brain Tumor Reports > Volume 19, Year 2017 > Number 12, December


CONTENTS



BRAIN TUMORS

GLIOMAS
- Brain stem gliomas
- - Diffuse intrinsic pontine gliomas
- High-grade gliomas
- Low-grade gliomas

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
- Glioblastoma
- Oligodendroglioma

EMBRYONAL TUMORS
- Medulloblastoma

LYMPHOMAS



BRAIN TUMORS



Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Butowski N, Fenstermaker RA, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Howard S, Junck L, Kaley T, Kumthekar P, Loeffler JS, Moots PL, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Ragsdale J 3rd, Rockhill J, Rogers L, Rusthoven C, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tsien C, Weiss S, Wen PY, Willmarth N, Bergman MA, Engh A.
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017.
J Natl Compr Canc Netw. 2017 Aug 17.
Source | Abstract | Full text | Similar articles




Sayour EJ, Mitchell DA.
Immunotherapy for Pediatric Brain Tumors.
Brain Sci. 2017 Oct 21;7(10). pii: E137. doi: 10.3390/brainsci7100137.
Source | Abstract | Full text | Similar articles




Yuan Y, Ross J, Shi Q, Davis FG.
Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000-2008.
Curr Oncol. 2017 Oct;24(5):e341-e347. doi: 10.3747/co.24.3579. Epub 2017 Oct 25.
Source | Abstract | Full text | Similar articles



GLIOMAS



[No authors listed]
Study Identifies Subtypes of Pediatric High-Grade Gliomas.
Cancer Discov. 2017 Oct 20. doi: 10.1158/2159-8290.CD-NB2017-145. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




[No authors listed]
Treating Recurrent Glioma with Toca 511.
Cancer Discov. 2017 Nov 8. doi: 10.1158/2159-8290.CD-NB2017-157. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



BRAIN STEM GLIOMAS


Diffuse intrinsic pontine gliomas



Kilburn LB, Kocak M, Baxter P, Poussaint TY, Paulino AC, McIntyre C, Lemenuel-Diot A, Lopez-Diaz C, Kun L, Chintagumpala M, Su JM, Broniscer A, Baker JN, Hwang EI, Fouladi M, Boyett JM, Blaney SM.
A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.
Pediatr Blood Cancer. 2017 Nov 1. doi: 10.1002/pbc.26832. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Moriya S, Ohba S, Adachi K, Nishiyama Y, Hayashi T, Nagahisa S, Kaito T, Nakae S, Hirose Y.
A retrospective study of bevacizumab for treatment of brainstem glioma with malignant features.
J Clin Neurosci. 2017 Oct 16. pii: S0967-5868(17)31445-5. doi: 10.1016/j.jocn.2017.10.002. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Tejada S, Alonso M, Patiño A, Fueyo J, Gomez-Manzano C, Diez-Valle R.
Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients.
Neurosurgery. 2017 Oct 27. doi: 10.1093/neuros/nyx507. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




van Zanten SEMV, El-Khouly FE, Jansen MHA, Bakker DP, Aliaga ES, Haasbeek CJA, Wolf NI, Zwaan CM, Vandertop WP, van Vuurden DG, Kaspers GJL.
Correction to: A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.
J Neurooncol. 2017 Oct 23. doi: 10.1007/s11060-017-2636-0. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



HIGH-GRADE GLIOMAS



Balañá C, Alonso M, Hernandez A, Perez-Segura P, Pineda E, Ramos A, Sanchez AR, Teixidor P, Verger E, Benavides M.
SEOM clinical guidelines for anaplastic gliomas (2017).
Clin Transl Oncol. 2017 Oct 20. doi: 10.1007/s12094-017-1762-7. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Møller S, Munck Af Rosenschöld P, Costa J, Law I, Poulsen HS, Engelholm SA, Engelholm S.
Toxicity and efficacy of re-irradiation of high-grade glioma in a phase I dose- and volume escalation trial.
Radiother Oncol. 2017 Oct 17. pii: S0167-8140(17)32625-7. doi: 10.1016/j.radonc.2017.09.039. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Butowski N, Fenstermaker RA, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Howard S, Junck L, Kaley T, Kumthekar P, Loeffler JS, Moots PL, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Ragsdale J 3rd, Rockhill J, Rogers L, Rusthoven C, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tsien C, Weiss S, Wen PY, Willmarth N, Bergman MA, Engh A.
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017.
J Natl Compr Canc Netw. 2017 Nov;15(11):1331-1345. doi: 10.6004/jnccn.2017.0166.
Source | Abstract | Full text | Similar articles




Yeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Contessa J, Yu JB.
Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas.
Radiother Oncol. 2017 Oct 17. pii: S0167-8140(17)32599-9. doi: 10.1016/j.radonc.2017.09.027. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



LOW-GRADE GLIOMAS



Sepúlveda-Sánchez JM, Muñoz Langa J, Arráez MÁ, Fuster J, Hernández Laín A, Reynés G, Rodríguez González V, Vicente E, Vidal Denis M, Gallego Ó.
SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).
Clin Transl Oncol. 2017 Nov 9. doi: 10.1007/s12094-017-1790-3. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



Umans RA, Sontheimer H.
Combating Malignant Astrocytes: Strategies Mitigating Tumor Invasion.
Neurosci Res. 2017 Oct 17. pii: S0168-0102(17)30552-7. doi: 10.1016/j.neures.2017.09.010. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



GLIOBLASTOMA



Aiken R, Axelson M, Harmenberg J, Klockare M, Larsson O, Wassberg C.
Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response.
Oncotarget. 2017 Sep 6;8(46):81501-81510. doi: 10.18632/oncotarget.20662. eCollection 2017 Oct 6.
Source | Abstract | Full text | Similar articles




Arrillaga-Romany I, Chi AS, Allen JE, Oster W, Wen PY, Batchelor TT.
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma.
Oncotarget. 2017 May 12;8(45):79298-79304. doi: 10.18632/oncotarget.17837. eCollection 2017 Oct 3.
Source | Abstract | Full text | Similar articles




Bastiancich C, Bastiat G, Lagarce F.
Gemcitabine and glioblastoma: challenges and current perspectives.
Drug Discov Today. 2017 Oct 23. pii: S1359-6446(17)30348-3. doi: 10.1016/j.drudis.2017.10.010. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Galuppini F, Opocher E, Tabori U, Mammi I, Edwards M, Campbell B, Kelly J, Viel A, Quaia M, Rivieri F, D'Avella D, Arcella A, Giangaspero F, Fassan M, Gardiman MP.
Concomitant IDH-wildtype glioblastoma and IDH1-mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome.
Neuropathol Appl Neurobiol. 2017 Nov 12. doi: 10.1111/nan.12450. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Gately L, McLachlan SA, Philip J, Ruben J, Dowling A.
Long-term survivors of glioblastoma: a closer look.
J Neurooncol. 2017 Oct 27. doi: 10.1007/s11060-017-2635-1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ghiaseddin A, Reardon D, Massey W, Mannerino A, Lipp ES, Herndon JE 2nd, McSherry F, Desjardins A, Randazzo D, Friedman HS, Peters KB.
Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.
Oncologist. 2017 Nov 13. pii: theoncologist.2017-0501. doi: 10.1634/theoncologist.2017-0501. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Martínez-Garcia M, Álvarez-Linera J, Carrato C, Ley L, Luque R, Maldonado X, Martínez-Aguillo M, Navarro LM, Vaz-Salgado MA, Gil-Gil M.
SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).
Clin Transl Oncol. 2017 Oct 30. doi: 10.1007/s12094-017-1763-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Osborn VW, Lee A, Garay E, Safdieh J, Schreiber D.
Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database.
Neurosurgery. 2017 Oct 28. doi: 10.1093/neuros/nyx497. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Pinto-Martin JA.
Where Is the Road Map for Glioblastoma?
JAMA Oncol. 2017 Oct 26. doi: 10.1001/jamaoncol.2017.3073. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Salma S, Djan I, Bjelan M, Vulekovic P, Novakovic M, Vidovic V, Lucic M.
Benefit and outcome of using temozolomide-based chemoradiotherapy followed by temozolomide alone for glioblastoma in clinical practice.
J BUON. 2017 Sep-Oct;22(5):1233-1239.
Source | Abstract | Full text | Similar articles




Shi W, Scannell Bryan M, Gilbert MR, Mehta MP, Blumenthal DT, Brown PD, Valeinis E, Hopkins K, Souhami L, Andrews DW, Tzuk-Shina T, Howard SP, Youssef EF, Lessard N, Dignam JJ, Werner-Wasik M.
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525.
Int J Radiat Oncol Biol Phys. 2017 Sep 4. pii: S0360-3016(17)33835-X. doi: 10.1016/j.ijrobp.2017.08.038. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Tarasenko N, Chekroun-Setti H, Nudelman A, Rephaeli A.
Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
J Cell Biochem. 2017 Nov 14. doi: 10.1002/jcb.26512. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Tini P, Nardone V, Pastina P, Battaglia G, Miracco C, Carbone SF, Sebaste L, Rubino G, Cerase A, Pirtoli L.
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide.
World Neurosurg. 2017 Oct 20. pii: S1878-8750(17)31779-5. doi: 10.1016/j.wneu.2017.10.052. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Tseng WL, Hsu HH, Chen Y, Tseng SH.
Tumor Recurrence in a Glioblastoma Patient after Discontinuation of Prolonged Temozolomide Treatment.
Asian J Neurosurg. 2017 Oct-Dec;12(4):727-730. doi: 10.4103/ajns.AJNS_39_15.
Source | Abstract | Full text | Similar articles




Yao Q, Cai G, Yu Q, Shen J, Gu Z, Chen J, Shi W, Shi J.
IDH1 mutation diminishes aggressive phenotype in glioma stem cells.
Int J Oncol. 2017 Nov 3. doi: 10.3892/ijo.2017.4186. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



OLIGODENDROGLIOMA



Goel NJ, Abdullah KG, Lang SS.
Outcomes and Prognostic Factors in Pediatric Oligodendroglioma: A Population-Based Study.
Pediatr Neurosurg. 2017 Nov 2. doi: 10.1159/000481458. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



EMBRYONAL TUMORS


MEDULLOBLASTOMA



Kumar V, Kumar V, McGuire T, Coulter DW, Sharp JG, Mahato RI.
Challenges and Recent Advances in Medulloblastoma Therapy.
Trends Pharmacol Sci. 2017 Oct 20. pii: S0165-6147(17)30181-5. doi: 10.1016/j.tips.2017.09.002. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Mokhtech M, Morris CG, Indelicato DJ, Rutenberg MS, Amdur RJ.
Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural Metastasis.
Am J Clin Oncol. 2017 Oct 17. doi: 10.1097/COC.0000000000000407. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



LYMPHOMAS



Ozdemir ES, Yildirim AE, Can AY.
Primary Central Nervous System Lymphoma of Optic Chiasma: Endoscopic Endonasal Treatment.
J Craniofac Surg. 2017 Oct 23. doi: 10.1097/SCS.0000000000004059. [Epub ahead of print]
Source | Abstract | Full text | Similar articles